23 related articles for article (PubMed ID: 3874857)
1. Antibacterial and hemocompatibility potentials of nano-gold-cored alginate preparation against anaerobic bacteria from acne vulgaris.
Abbas HA; Taha AA; Sulaiman GM; Al Ali A; Shmrany HA; Stamatis H; Mohammed HA; Khan RA
Sci Rep; 2024 Mar; 14(1):6984. PubMed ID: 38523189
[TBL] [Abstract][Full Text] [Related]
2. Effect of inoculum size on bacteriolytic activity of cefminox and four other beta-lactam antibiotics against Escherichia coli.
Soriano F; Edwards R; Greenwood D
Antimicrob Agents Chemother; 1992 Jan; 36(1):223-6. PubMed ID: 1590693
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of cefminox against anaerobic bacteria compared with those of nine other compounds.
Hoellman DB; Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Mar; 42(3):495-501. PubMed ID: 9517922
[TBL] [Abstract][Full Text] [Related]
4. [Antibacterial activity of MT-141 against anaerobic bacteria].
Watanabe T; Hara T; Kasai T; Ishii T; Miyauchi K; Date H; Jinzaki M; Shindo H; Matsugami A; Goi H
Jpn J Antibiot; 1984 Jun; 37(6):1058-69. PubMed ID: 6092738
[TBL] [Abstract][Full Text] [Related]
5. European collaborative study of reproducibility of quantitative sensitivity testing of anaerobes.
King A; Phillips I
J Antimicrob Chemother; 1988 Apr; 21(4):425-38. PubMed ID: 3378957
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of cefbuperazone against anaerobic bacteria.
Wexler H; Carter WT; Harris BH; Finegold SM
Antimicrob Agents Chemother; 1985 Apr; 27(4):674-6. PubMed ID: 3847274
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of cefbuperazone, a new cephamycin, against anaerobic bacteria.
Prabhala RH; Thadepalli H; Rao B; Bansal MB; Marshall R
Antimicrob Agents Chemother; 1985 Apr; 27(4):640-2. PubMed ID: 4004195
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of cefminox against anaerobes.
Watanabe K; Sawa K; Bunai M; Ueno K
J Antibiot (Tokyo); 1985 May; 38(5):649-60. PubMed ID: 3874857
[TBL] [Abstract][Full Text] [Related]
9. Cefoxitin and cephamycins: microbiological studies.
Stapley EO; Birnbaum J; Miller AK; Wallick H; Hendlin D; Woodruff HB
Rev Infect Dis; 1979; 1(1):73-89. PubMed ID: 400941
[TBL] [Abstract][Full Text] [Related]
10. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
Aldridge KE
Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of anaerobic bacteria to beta-lactam antibiotics in the United States.
Johnson CC
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S371-6. PubMed ID: 8324150
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]